Fingerprint
Dive into the research topics of 'A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
Vikas Gupta, Ruben A. Mesa, Michael W.N. Deininger, Candido E. Rivera, Shireen Sirhan, Carrie Baker Brachmann, Helen Collins, Jun Kawashima, Yan Xin, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
46
Scopus
citations